During the last session, Entero Therapeutics Inc (NASDAQ:ENTO)’s traded shares were 95416.0, with the beta value of the company hitting 0.80. The 52-week high for the ENTO share is $3.40, that puts it down -794.74 from that peak though still a striking 50.0% gain since the share price plummeted to a 52-week low of $0.19. The company’s market capitalization is $1.81M, and the average intraday trading volume over the past 10 days was 1.96 million shares, and the average trade volume was 659.40K shares over the past three months.
Entero Therapeutics Inc (NASDAQ:ENTO) trade information
Entero Therapeutics Inc (ENTO) registered a -0.73% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -0.73% in intraday trading to $0.38, hitting a weekly high. The stock’s 5-day price performance is -6.15%, and it has moved by -28.24% in 30 days. Based on these gigs, the overall price performance for the year is -87.48%. The short interest in Entero Therapeutics Inc (NASDAQ:ENTO) is 0.12 million shares and it means that shorts have 0.23 day(s) to cover.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 82.03%.
ENTO Dividends
Entero Therapeutics Inc is due to release its next quarterly earnings on 2025-Mar-31. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Entero Therapeutics Inc (NASDAQ:ENTO)’s Major holders
Entero Therapeutics Inc insiders own 3.75% of total outstanding shares while institutional holders control 1.51%, with the float percentage being 1.57%.
Also, the Mutual Funds coming in first place with the largest holdings of Entero Therapeutics Inc (ENTO) shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . Data provided on Feb 28, 2025 indicates that Fidelity Concord Street Trust-Fidelity Extended Market Index Fund owns about 15.05 shares. This amounts to just over 0.32 percent of the company’s overall shares, with a $5693.0 market value. The same data shows that the other fund manager holds slightly less at 4.54, or about 0.10% of the stock, which is worth about $1715.0.
